| Phenomics Australia |
South Australia Genome Editing Facility (Uni of Adelaide) |
Biobanking and in vivo genome engineering and disease modelling |
Paul Thomas |
|
| Phenomics Australia |
Monash Genome Modification Platform (Monash University) |
Biobanking and in vivo genome engineering and disease modelling |
Alexander Combes |
|
| Phenomics Australia |
Australian Transgenic Drosophila Facility |
Biobanking and in vivo genome engineering and disease modelling |
Kieran Harvey |
|
| Phenomics Australia |
The Australian Phenome Bank (ANU) |
Biobanking and in vivo genome engineering and disease modelling |
Nathalie Doucet |
|
| Phenomics Australia |
Melbourne Advanced Genome Editing Centre (ONJCRI) |
Biobanking and in vivo genome engineering and disease modelling |
Andrew Kueh |
|
| TIA |
CSIRO Biomedical Manufacturing |
Biologics and Vaccines |
Patrick James |
|
| TIA |
Protein Expression Facility (PEF) |
Biologics and Vaccines |
David Owen |
|
| TIA |
National Biologics Facility (UQ) |
Biologics and Vaccines |
Martina Jones |
|
| TIA |
Recombinant Products Facility (UNSW RPF) |
Biologics and Vaccines |
Helene Lebhar |
Christopher Marquis |
| TIA |
Biologics Innovation Facility (UTS) |
Biologics and Vaccines |
Andrew Care |
|
| TIA |
Cell Therapies Pty Ltd |
Cell & Gene Therapies |
Jennifer Hollands |
|
| TIA |
Cell & Tissue Therapies WA (Royal Perth Hospital) |
Cell & Gene Therapies |
Zlatibor Velickovic |
|
| TIA |
Cell & Molecular Therapies (Royal Prince Alfred Hospital) |
Cell & Gene Therapies |
Sharon Sagnella |
|
| TIA |
Sydney Cell and Gene Therapy (Westmead Precinct) |
Cell & Gene Therapies |
Leighton Clancy |
|
| TIA |
Functional Genomics South Australia (Uni of Adelaide) |
Cell & Gene Therapies |
Jason Gummow |
Simon Barry |
| TIA |
Vector and Genome Engineering Facility (CMRI) |
Cell & Gene Therapies |
Josh Studdert |
|
| TIA |
Centre of Excellence in Cellular Immunotherapy (Peter Mac) |
Cell & Gene Therapies |
Gretchen Poortinga |
|
| TIA |
Q-Gen Cell Therapeutics (QIMR Berghofer) |
Cell & Gene Therapies |
Suzannah Walden |
|
| TIA |
Preclinical, Imaging and Research Laboratories (PIRL) |
GLP toxicology |
Adam O'Connell |
Tamara Varcoe |
| Phenomics Australia |
Monash Functional Genomics Platform (Monash University) |
High Throughput Screening |
Sefi Rosenbluh |
|
| Phenomics Australia |
Functional Genomics South Australia (Uni of Adelaide) |
High Throughput Screening |
Jason Gummow |
Simon Barry |
| TIA |
Community for Open Antimicrobial Drug Discovery (UQ) |
High Throughput Screening |
Johannes Zuegg |
Mark Blaskovich |
| TIA |
Griffith Discovery Biology (Griffith University) |
High Throughput Screening |
Vicky Avery |
|
| TIA |
ACRF Drug Discovery Centre for Childhood Cancer (Children's Cancer Institute) |
High Throughput Screening |
Tim Failes |
|
| TIA |
IBG Nathan Mass Spec Facility (Griffith University) |
High Throughput Screening |
Wendy Loa |
|
| TIA |
Stafford Fox Drug Discovery Facility (MCRI) |
High Throughput Screening |
Alejandro Hidalgo Gonzalez |
|
| TIA |
Monash Fragment Platform (Monash University) |
High Throughput Screening |
Luke Adams |
Martin Scanlon |
| TIA |
Cell Function & Screening Facility (VCCRI Innovation Centre) |
High Throughput Screening |
Jacek Kolanowski |
|
| TIA |
National Drug Discovery Centre (WEHI) |
High Throughput Screening |
Jeff Mitchell |
Kym Lowes |
| TIA / Phenomics Australia |
ANU Centre for Therapeutic Discovery (ANU) |
High Throughput Screening |
Amee George |
|
| TIA / Phenomics Australia |
Victorian Centre for Functional Genomics (Peter Mac) |
High Throughput Screening |
Kaylene Simpson |
|
| Phenomics Australia |
Australian Organoid Facility (UQ) |
In vitro genome engineering and disease modelling |
Andrew Prowse |
Nathan Godde |
| Phenomics Australia |
Genome Engineering and Disease Modelling Service (UQ) |
In vitro genome engineering and disease modelling |
Andrew Prowse |
|
| Phenomics Australia |
Stem Cell Disease Modelling Laboratory (Uni of Melbourne) |
In vitro genome engineering and disease modelling |
Alice Pébay |
|
| Phenomics Australia |
Translational Cancer Research Program (Harry Perkins Institute of Medical Research) |
In vitro genome engineering and disease modelling |
Louise Winteringham |
|
| Phenomics Australia |
Induced Pluripotent Stem Cell Derivation & CRISPR Gene Editing Facility (MCRI) |
In vitro genome engineering and disease modelling |
Sara Howden |
|
| Phenomics Australia |
Monash Organoid Program (Monash University) |
In vitro genome engineering and disease modelling |
Thierry Jarde |
|
| Phenomics Australia |
Stem Cell Production Facility (VCCRI Innovation Centre) |
In vitro genome engineering and disease modelling |
Jacek Kolanowski |
|
| Phenomics Australia |
Histopathology and Digital Slide Service (Uni of Melbourne) |
Pathology |
Janet Keast |
Tina Cardamone |
| TIA |
BASE Facility (UQ) |
RNA Products |
Tim Mercer |
Rachel Chang |
| TIA |
mRNA CORE (Monash) |
RNA Products |
Colin Pouton |
Emily Pilkington |
| TIA |
RNA Institute (UNSW) |
RNA Products |
Palli Thordarson |
Joshua Peterson |
| TIA |
RNA Innovation Foundry (UWA) |
RNA Products |
Archa Fox |
Olga Shimoni |
| TIA |
Drug Target Identification (Monash Universtity) |
Small Molecule Therapeutics |
Darren Creek |
|
| TIA |
CSIRO Biomedical Manufacturing |
Small Molecule Therapeutics |
Mark York |
|
| TIA |
Ab Initio Pharma |
Small Molecule Therapeutics |
Hui Xin Ong |
|
| TIA |
Centre for Integrated Preclinical Drug Development (UQ) |
Small Molecule Therapeutics |
Maree Smith |
Andy Kuo |
| TIA |
Qld Emory Drug Discovery Initiative |
Small Molecule Therapeutics |
Andrew Harvey |
Brian Dymock |
| TIA |
Compounds Australia (Griffith University) |
Small Molecule Therapeutics |
Rebecca Lang |
Nyssa Drinkwater |
| TIA |
Australian Translational Medicinal Chemistry Facility (Monash University) |
Small Molecule Therapeutics |
Paul Stupple |
Leanne Hawkey |
| TIA |
Centre for Drug Candidate Optimisation (Monash University) |
Small Molecule Therapeutics |
Joseph Nicolazzo |
Alex Stupple |
| TIA |
MMIC (Monash University) |
Small Molecule Therapeutics |
Tri-Hung Nguyen |
|
